Navigation Links
Pharmacyclics Reports Second Quarter 2013 Results
Date:7/31/2013

dy of ibrutinib in combination with R-CHOP in patients with newly diagnosed CD20 positive B-cell Non Hodgkin Lymphoma (DLBCL, MCL, FL). The purpose of this study is to identify a safe and tolerable dose of ibrutinib in combination with R-CHOP. This global, multi-center study, conducted by Janssen, has been fully accrued with 17 patients and an update on the dose escalating phase of this study was provided at ASCO 2013.With a recommended Phase II dose established, the study has enrolled additional 15 patients with newly diagnosed DLBCL and is currently in the expansion phase.
  • DBL3001: Phase III study of ibrutinib in combination with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) in patients with newly diagnosed non-germinal center B-cell subtype of DLBCL. This trial is a randomized, multi-center, double-blinded, controlled trial of ibrutinib plus R-CHOP versus R-CHOP in patients with newly diagnosed non-GCB subtype DLBCL. The primary endpoint of the study is to demonstrate a clinically significant improvement in event-free survival when compared to R-CHOP. This global study, conducted by Janssen, is not yet recruiting and Janssen plans to enroll 800 patients worldwide.
  • FL

  • FLR2002: Phase II study of ibrutinib in patients with R/R follicular lymphoma (FL). This is a multi-center, global study of ibrutinib in patients with chemoimmunotherapy-resistant FL, whose disease has relapsed from at least 2 prior lines of therapy, including at least 1 rituximab combination chemotherapy regimen. The primary endpoint of this study is objective response rate. This global study, conducted by Janssen, is recruiting and Janssen plans to enroll 110 patients.
  • WM

  • NCI STUDY: Phase II study of ibrutinib in patients with R/R WM. This is a multicenter, open label study with a primary endpoint of ORR and is currently exploring ibrutinib administration at 420 mg in patients with WM who have failed at least 1 prior thera
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    2. Pharmacyclics Reports First Quarter 2013 Results
    3. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    4. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    5. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    6. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    7. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    8. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    9. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    10. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
    11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
    (Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/5tzcx6/specialty_enzymes ) has announced ... Strategic Business Report" report to their offering. ... End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and Others. ... Canada , Japan ... , Latin America , and ...
    (Date:6/2/2015)... PITTSBURGH , June 2, 2015 ... technology (HIT) consulting firm, today announced the celebration ... organizations served throughout the U.S., since its inception ... for a skillful workforce in the healthcare technology ... resources with a company-wide dedication to facilitating clients, ...
    Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
    ... 23, 2012 IRIDEX Corporation (NASDAQ: IRIX ) today ... 2011 financial results after the market closes on Thursday, ... Company will host a conference call with the investment community at ... Thursday, March 1, 2012 to discuss the results of ...
    ... 2012 A United States federal judge in New ... conglomerate 3M against Harvey Boulter, the CEO of investment fund manager ... dispute. The claims made by 3M that Mr Boulter ... Vindication for Porton Group in New York follows the decision earlier ...
    Cached Medicine Technology:Blackmail Claims Against Harvey Boulter Thrown out of Court 2
    (Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers can ... person. , According to Psychology Today, humans are a curious ... that curiosity is a part of human development. People are ...
    (Date:6/2/2015)... USA (PRWEB) June 02, 2015 Tronics, ... is deploying its growth strategy to benefit from the ... “In Yole Développement’s May 2015 Status of the MEMS ... grow sharply and reach $6.6B in 2020,” says Frederic ... Yole Développement . , The analyst adds that “although ...
    (Date:6/2/2015)... October 1, 2015 the transition to ICD-10 will happen ... Monday, June 1st Congressman Kevin Brady, chairman of ... Committee, and 12 members of the Committee sent a ... the administration to provide a smooth transition for local ... newest coding system for healthcare professionals to code diseases, ...
    (Date:6/2/2015)... 02, 2015 Erbelli’s Gourmet Pizzeria, Italian ... promote its handmade gourmet pizzas and calzones, fresh wraps, ... website is new, the recipes are not—they have been ... main feature of the site is the menu, which ... descriptions of all the items. You can order directly ...
    (Date:6/2/2015)... Claflin Medical Equipment , a ... acquisition of RSI Equipment, Inc ., a ... 2015. , With CME’s recent merger of Hospital ... three premier organizations which specialize in the procurement and ... By combining forces, they now cover the entire country ...
    Breaking Medicine News(10 mins):Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2
    ... soul, as the old adage goes, but scientists are reporting evidence ... basis for a long-sought test to detect infection with the agent ... disease from spreading in the food supply. A study on using ... Cow agent appears in ACS, semi-monthly journal Analytical Chemistry . ...
    ... fatigue is often a major problem for cancer ... completing therapy. Researchers at Mayo Clinic ( http://www.mayoclinic.org/oncology-rst/ ... ( http://ncctg.mayo.edu/ ) (NCCTG) recently completed a study ... and found that, while it did not improve ...
    ... ... advice to help you make the most out of this important event in your life. ... Richmond, VA (PRWEB) June 2, 2010 -- ... most popular month for weddings in the U.S. and getting married not only is one of ...
    ... 1, 2010 Middle-aged Canadians are much less worried about ... close to panic, says an Alberta researcher who has just ... differing attitudes today may foreshadow growing differences between the two ... McDaniel, a sociology researcher and demographics expert, has been working ...
    ... took ketorolac after mastectomy fared better, researchers say , ... woman takes after a mastectomy may influence the odds ... Researchers at the Catholic University of Louvain (Leuven) in ... cancer recurrence in 327 women from one to four ...
    ... ... ,Holy Grail, of cosmetic laser treatments for stretch marks and scars which could help up to ... (PRWEB) May 30, ... approved fractional laser treatment for stretch marks on the market, which promises to reduce the appearance ...
    Cached Medicine News:Health News:Results from a study testing methylphenidate for cancer-related fatigue 2Health News:Results from a study testing methylphenidate for cancer-related fatigue 3Health News:A Good Night's Sleep Can Help Reduce June Wedding Planning Stress 2Health News:Survey highlights major Canada-US differences in people in middle age 2Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 2Health News:The Harley Medical group launches exclusive treatment for stretch marks and scars 3
    The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
    The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical micr...
    The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
    The DEI 750 MD from Optronics is a surgical 3 CCD color microscope camera with a 10 meter head cable. Easily mounts on your microscopes C-mount adapter and is the best choice for your surgical imagin...
    Medicine Products: